BioLASCO Taiwan Co., Ltd. (TPEX:6662)

Market Cap	778.60M -15.3%
Revenue (ttm)	262.66M -10.2%
Net Income	42.43M -3.6%
EPS	1.65 -4.0%
Shares Out	25.61M
PE Ratio	18.42
Forward PE	n/a
Dividend	1.50 (4.93%)
Ex-Dividend Date	Aug 7, 2025

Volume	2,006
Average Volume	9,819
Open	29.50
Previous Close	30.40
Day's Range	29.30 - 31.85
52-Week Range	28.05 - 35.80
Beta	0.19
RSI	56.75
Earnings Date	Mar 27, 2026

About BioLASCO Taiwan

BioLASCO Taiwan Co., Ltd. operates an animal breeding center to produce specific pathogen-free laboratory mice and rats in Taiwan and internationally. It offers lab animals, such as rat, mice, and others, as well as surgical services; rodents housing, washing solutions, workstations, animal housing and management solutions, lab animal research equipment, clean solution, preclinical imaging system, and experimental equipment; various reagents, including lab animal diagnostic reagent, endotoxin testing system, portable endotoxin testing system, r...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 91
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6662

Financial Performance

In 2025, BioLASCO Taiwan's revenue was 262.66 million, a decrease of -10.20% compared to the previous year's 292.50 million. Earnings were 42.43 million, a decrease of -3.63%.